Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

In vivo efficacy of anidulafungin against mature Candida albicans biofilms in a novel rat model of catheter-associated Candidiasis.

Kucharíková S, Tournu H, Holtappels M, Van Dijck P, Lagrou K.

Antimicrob Agents Chemother. 2010 Oct;54(10):4474-5. doi: 10.1128/AAC.00697-10. Epub 2010 Jul 26.

2.

Activities of systemically administered echinocandins against in vivo mature Candida albicans biofilms developed in a rat subcutaneous model.

Kucharíková S, Sharma N, Spriet I, Maertens J, Van Dijck P, Lagrou K.

Antimicrob Agents Chemother. 2013 May;57(5):2365-8. doi: 10.1128/AAC.02288-12. Epub 2013 Feb 12.

3.

The nonsteroidal antiinflammatory drug diclofenac potentiates the in vivo activity of caspofungin against Candida albicans biofilms.

Bink A, Kucharíková S, Neirinck B, Vleugels J, Van Dijck P, Cammue BP, Thevissen K.

J Infect Dis. 2012 Dec 1;206(11):1790-7. doi: 10.1093/infdis/jis594. Epub 2012 Sep 14.

PMID:
22984120
4.

[In vitro activity of amphotericin B and anidulafungin against Candida spp. biofilms].

Valentín A, Cantón E, Pemán J, Quindós G.

Rev Iberoam Micol. 2007 Dec 31;24(4):272-7. Spanish.

5.

Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis.

Lazzell AL, Chaturvedi AK, Pierce CG, Prasad D, Uppuluri P, Lopez-Ribot JL.

J Antimicrob Chemother. 2009 Sep;64(3):567-70. doi: 10.1093/jac/dkp242. Epub 2009 Jul 7.

PMID:
19584104
6.

Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii.

Simitsopoulou M, Kyrpitzi D, Velegraki A, Walsh TJ, Roilides E.

Antimicrob Agents Chemother. 2014 Aug;58(8):4953-6. doi: 10.1128/AAC.03117-14. Epub 2014 Jun 2.

7.

In vitro activity of anidulafungin against Candida albicans biofilms.

Jacobson MJ, Piper KE, Nguyen G, Steckelberg JM, Patel R.

Antimicrob Agents Chemother. 2008 Jun;52(6):2242-3. doi: 10.1128/AAC.00211-08. Epub 2008 Apr 7.

8.

Antifungal activity against planktonic and biofilm Candida albicans in an experimental model of foreign-body infection.

Maiolo EM, Oliva A, Furustrand Tafin U, Perrotet N, Borens O, Trampuz A.

J Infect. 2016 Mar;72(3):386-92. doi: 10.1016/j.jinf.2015.12.008. Epub 2015 Dec 24.

PMID:
26723911
9.

In vitro effectiveness of anidulafungin against Candida sp. biofilms.

Rosato A, Piarulli M, Schiavone BP, Catalano A, Carocci A, Carrieri A, Carone A, Caggiano G, Franchini C, Corbo F, Montagna MT.

J Antibiot (Tokyo). 2013 Dec;66(12):701-4. doi: 10.1038/ja.2013.83. Epub 2013 Sep 11.

PMID:
24022607
10.

In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth.

Cateau E, Rodier MH, Imbert C.

J Antimicrob Chemother. 2008 Jul;62(1):153-5. doi: 10.1093/jac/dkn160. Epub 2008 Apr 10.

PMID:
18407917
11.

Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms.

Katragkou A, Chatzimoschou A, Simitsopoulou M, Dalakiouridou M, Diza-Mataftsi E, Tsantali C, Roilides E.

Antimicrob Agents Chemother. 2008 Jan;52(1):357-60. Epub 2007 Oct 15.

12.

[Activity of anidulafungin against Candida biofilms].

Pemán J, Cantón E, Valentín A.

Rev Iberoam Micol. 2008 Jun;25(2):124-8. Review. Spanish.

13.

Antifungal lock therapy.

Walraven CJ, Lee SA.

Antimicrob Agents Chemother. 2013 Jan;57(1):1-8. doi: 10.1128/AAC.01351-12. Epub 2012 Oct 15. Review.

14.

Amphotericin B lipid complex is efficacious in the treatment of Candida albicans biofilms using a model of catheter-associated Candida biofilms.

Mukherjee PK, Long L, Kim HG, Ghannoum MA.

Int J Antimicrob Agents. 2009 Feb;33(2):149-53. doi: 10.1016/j.ijantimicag.2008.07.030. Epub 2008 Oct 21.

PMID:
18945596
15.

The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems.

Ghannoum M, Roilides E, Katragkou A, Petraitis V, Walsh TJ.

Clin Infect Dis. 2015 Dec 1;61 Suppl 6:S618-21. doi: 10.1093/cid/civ815.

PMID:
26567279
16.

Efficacy of anidulafungin in the treatment of experimental Candida parapsilosis catheter infection using an antifungal-lock technique.

Basas J, Morer A, Ratia C, Martín MT, Del Pozo JL, Gomis X, Rojo-Molinero E, Torrents E, Almirante B, Gavaldà J.

J Antimicrob Chemother. 2016 Oct;71(10):2895-901. doi: 10.1093/jac/dkw251. Epub 2016 Jul 4.

PMID:
27378814
17.

Antifungal susceptibility of Candida albicans in biofilms.

Tobudic S, Kratzer C, Lassnigg A, Presterl E.

Mycoses. 2012 May;55(3):199-204. doi: 10.1111/j.1439-0507.2011.02076.x. Epub 2011 Jul 28. Review.

PMID:
21793943
18.

[Activity of micafungin against Candida biofilms].

Quindós G, Villar-Vidal M, Eraso E.

Rev Iberoam Micol. 2009 Mar 31;26(1):49-55. doi: 10.1016/S1130-1406(09)70008-7. Epub 2009 May 7. Review. Spanish.

19.

In vivo Candida glabrata biofilm development on foreign bodies in a rat subcutaneous model.

Kucharíková S, Neirinck B, Sharma N, Vleugels J, Lagrou K, Van Dijck P.

J Antimicrob Chemother. 2015 Mar;70(3):846-56. doi: 10.1093/jac/dku447. Epub 2014 Nov 17.

PMID:
25406296
20.

Polymer multilayers loaded with antifungal β-peptides kill planktonic Candida albicans and reduce formation of fungal biofilms on the surfaces of flexible catheter tubes.

Raman N, Lee MR, Palecek SP, Lynn DM.

J Control Release. 2014 Oct 10;191:54-62. doi: 10.1016/j.jconrel.2014.05.026. Epub 2014 May 24.

Supplemental Content

Support Center